| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |